A cohort study of more than 900 pregnant persons has found that monoclonal antibody (mAb) treatment for mild to moderate COVID-19 is safe for clinical use. Reported adverse effects were also rare and mild. The study is published in Annals of Internal Medicine.
from Medical Xpress - latest medical and health news stories https://ift.tt/6fpiIHg
